General Mills (GIS) Q4 2026 Earnings Call Transcript

General Mills reported FY2026 Q4 net sales of $4.6B (+1%), but swung to an operating loss of $2.1B largely due to $1.8B of non-cash goodwill/brand impairment and a $1.0B Brazil divestiture valuation loss. Adjusted diluted EPS was $0.95 (+27% in constant currency), yet management guided FY2027 organic net sales to a range of -1.5% to +0.5% and adjusted operating profit to decline 8%-13% (constant currency) versus the $2.8B base. The company expects net input-cost inflation of 4%-5% for FY2027 (covered ~8–9 months) and targets $3B in cumulative cost savings through fiscal 2030 (including $750M in FY2027), with share repurchases of $500M in FY2026.

Analysis

This reads like a classic mature-staples reset: management is effectively swapping one-time pricing repair for a multi-quarter proof point on innovation, which usually pressures the multiple before it helps the P&L. The near-term issue is not just weak volume; it is that mix-driven improvements can mask still-fragile unit economics, so the market may not reward “better” unless it sees sustained take-rate and not just packaged up trading.

The second-order loser is any adjacent brand portfolio fighting for the same shelf space and shopper wallet in frozen, cereal, and pet. The inventory commentary matters because lower-stock e-commerce and mass channels can keep sell-through fine while sell-in stays noisy, creating apparent demand volatility that can persist for 1-2 quarters and delay confidence in the turnaround. The cost-savings plan is supportive, but it is more a margin backstop than a growth catalyst; that tends to cap upside when the core top line is still shrinking.

Contrarianly, the selloff can overshoot if investors are ignoring cash conversion and the fact that the impairment is largely non-cash, while also underestimating how much operating leverage comes from even modest mix improvement. The thesis is falsified if Q1 shows a cleaner sell-in/sell-through bridge, no further share loss, and gross margin does not sag despite inflation. Absent that, the back-half recovery story is too dependent on execution and deserves a lower multiple for at least the next 1-3 months.

Key Decisions for Investors

• Short GIS on strength / after any post-call bounce; expect near-term multiple compression as FY27 guidance implies earnings pressure before savings become visible. Cover if next-quarter organic sales inflects positive and gross margin holds despite inflation.
• Buy a 3-6 month GIS put spread to express downside with defined risk; best setup is into the next earnings print if sell-in still lags sell-through. Target roughly 1.5-2.0x risk/reward if the stock re-rates toward a lower staples multiple.
• Relative-value idea: short GIS vs long PG on quality and pricing-power divergence. The pair favors the company with cleaner premiumization and less dependence on a turnaround narrative.
• Watch item, not a trade yet: if pet inventory noise persists beyond one quarter, reassess the durability of the FY27 back-half margin recovery thesis. That would be the main falsifier for any bearish position.